Skip to main content
. 2016 Jun 30;3(5):e257. doi: 10.1212/NXI.0000000000000257

Table 2.

Detailed clinical characteristics of 5 patients with MS who had antibodies to myelin oligodendrocyte glycoprotein

graphic file with name NEURIMMINFL2016009266TT2.jpg